Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04178746 · ClinicalTrials.gov registry record
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
A clinical trial, sponsored by Penumbra.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04178746 is a clinical trial that was terminated before completion, run by Penumbra. The registered enrollment target is 4 participants.
The verdict
NCT04178746 was terminated before completion, sponsored by Penumbra.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this prospective, single center, single arm registry is to assess technical feasibility, peri-procedural complications, post-procedure imaging outcomes, and 30-day safety outcomes in subjects with intraventricular hemorrhages utilizing the Artemis Neuro Evacuation Device in the hyper-acute phase.
Interventions
- DEVICE Artemis Neuro Evacuation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-09-26 |
| Est. Completion | 2021-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04178746
The ClinicalTrials.gov registry entry for NCT04178746 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artemis Neuro Evacuation Device is the first listed.
NCT04178746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04178746 about?
NCT04178746 is a clinical study titled "PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase". The purpose of this prospective, single center, single arm registry is to assess technical feasibility, peri-procedural complications, post-procedure imaging outcomes, and 30-day safety outcomes in subjects with intraventricular hemorrhages utilizing the Artemis Neuro Evacuation Device in the hyper-...
What is the current status of trial NCT04178746?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2019-09-26. Estimated completion is 2021-06-02.
What interventions are being tested in trial NCT04178746?
The interventions under investigation include: Artemis Neuro Evacuation Device (DEVICE).
Who is sponsoring clinical trial NCT04178746?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.